Drug Discovery

share

Soligenix (SNGX), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation,...

share

HedgePath Pharmaceuticals (HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for...

share

Swiss drugmaker Roche has partnered with Janus Biotherapeutics to develop a small molecule toll-like receptor (TLR) inhibitor with...

share

Researchers at the Centenary Institute at the University of Sydney have advanced the development of a new class...

share

Cancer Research UK’s Drug Discovery Committee is awarded an additional £5m to Newcastle University’s Northern Institute of Cancer...

share

Positive results of Symbiomix Therapeutics' first pivotal trial for lead drug candidate SYM-1219, a single-dose, oral product candidate...

share

Eisai and Halozyme Therapeutics have agreed to evaluate the combination of their drugs, Halaven (eribulin) and PEGPH20 (PEGylated...

share

Kyowa Hakko Kirin and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement to conduct a Phase...